Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.
Propofol Sedation of More Than 200 mg Enables Patients to Drive Home After Outpatient Colonoscopy Including Colorectal Polypectomy
1 other identifier
observational
300
1 country
1
Brief Summary
This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2022
CompletedStudy Start
First participant enrolled
January 16, 2022
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 18, 2025
May 1, 2025
3 years
January 15, 2022
May 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Traffic accidents
Number of traffic accidents
1 day
Secondary Outcomes (1)
Patient satisfaction
1 day
Interventions
Using \> 200 mg of propofol sedation colonoscopy is performed. 90-120 minutes after colonoscopy subjects go home. Within 1 week patients will be asked about their condition and satisfaction for colonoscopy.
Eligibility Criteria
healthy subjects who drive home after colonoscopy using propofol sedation (\>200 mg)
You may qualify if:
- subjects who drive home by theirselves after colonoscopy using propofol sedation (\>200 mg)
You may not qualify if:
- Subjects who received emergency procedures
- less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight \>100 kg) allergic to the drugs used or its components (soybeans or eggs).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Showa Inan General hospital
Komagane, Nagano, 399-4191, Japan
Related Publications (1)
Horiuchi I, Horiuchi K, Kitahara H, Horiuchi A. Does >200 mg of Propofol Sedation Allow Healthy Individuals to Undergo a Colonoscopy and Drive Themselves Home? J Clin Gastroenterol. 2025 Sep 30. doi: 10.1097/MCG.0000000000002252. Online ahead of print.
PMID: 41071172DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Digestive Disease Center
Study Record Dates
First Submitted
January 15, 2022
First Posted
January 28, 2022
Study Start
January 16, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 18, 2025
Record last verified: 2025-05